Siblings who are asked to donate haematopoietic stem cells are in a vulnerable position. Potential sibling donors must be fully informed, orally and in writing, and be able to provide informed consent without pressure or coercion.
1,2,3 To achieve this, one must focus on the management of confidentiality in terms of donor volunteer status and strive to protect the integrity of the sibling. 4, 5 At our centre we decided to improve this aspect in the care of potential sibling donors, enabling an early termination of the process for those not willing or unable to donate. We also wanted to improve the information to, and the follow-up of sibling donors.
In September 2005, a novel structure for the management and care of potential sibling donors was introduced at our centre. A fundamental change was that all physicians within our referring region were instructed not to perform HLAtyping of siblings by themselves. Instead, the physicians were asked to provide our transplantation (stem cell transplantation (SCT)) coordinator with identity data of the siblings, after their consent. The SCT-coordinator administers all further contacts with the siblings and also their HLA-typing. First, a written information folder about HLA-typing and haematopoietic stem cells donation, stressing that typing and donation are voluntary, is sent to the siblings. An initial telephone contact is then made by the SCT-coordinator, giving the sibling an opportunity to ask questions and to decline HLA-typing and donation. If there are any doubts about the suitability of the sibling as a donor, a visit to the SCT physician, including extended information and a medical check-up, is undertaken before HLA-typing is performed. If a sibling is willing to donate and declares himself/herself to be healthy, samples for HLA-typing are drawn without any prior visit. Siblings who decline to donate or who already have obvious medical contraindications at the time of the initial telephone contact are not typed. The SCT-secretariat receives HLA-typing results of all the siblings. However, these are not sent to the physician responsible for the patient. The SCT physician makes a note in the patient's record that (a) there is an HLA-matched potential sibling donor(s) and the donor identity(ies) or (b) the patient has no suitable sibling donor, but no reason is given for why the sibling(s) cannot donate, and the patient never receives information about the reason.
The siblings who are HLA-typed but not matched with the patient receive a letter containing this information and are offered contact with the SCT-coordinator for further information. All HLA-identical siblings receive a phone call from the coordinator and an appointment is scheduled. The appointment lasts for approximately 3 h and includes health investigation and extended information given by the SCT-physician and the SCT-nurse/SCT-coordinator. The physician and the nurse who meet the sibling are never those responsible for the patient. Usually the sibling makes one additional visit to the SCT-nurse to allow further information and instruction on how to inject G-CSF. At the time of donation the sibling is taken care of by the same physician and nurse as he/she met at the first appointment.
One month after haematopoietic stem cell donation there is a follow-up contact with the SCT-coordinator including the collection of blood samples and opportunity to ask questions. Contact with the SCT-physician is arranged if requested. Six months after the donation the donor receives a letter offering the opportunity of further contact and follow-up.
From September 2005 until December 2007 we handled 131 adult (18-64 years) siblings of potential allogeneic SCT-recipients (Figure 1) . One hundred and twenty of these siblings were HLA-typed. The reasons for why 11 siblings were not HLA-typed were that 5 siblings declined typing and donation, 4 siblings were excluded due to medical reasons and for 2 siblings typing was postponed due to logistics. Among the HLA-typed siblings, 31 (26%) matched the recipient, and 17 of these have donated. The reasons for not donating stem cells in 14 cases were cancellation of transplantation due to the patient's disease or treatment, that another HLA-identical sibling was used as donor or that they are still waiting to donate. No sibling shown to be HLA matched has declined to donate.
Our results indicate that 5-10% of potential sibling donors are not suitable for HLA-typing, either for medical reasons or from lack of consent. It is important to identify these individuals as early as possible. One reason is that the search for a registry donor, if indicated, should not be delayed. Another reason is to avoid the extra pressure that these siblings may experience if they are shown to be HLAmatched but not capable of donation for medical or psychological reasons. We find it most important to care for the potential donor as a patient, not merely as the sibling of a patient. Often, the donor has many thoughts and questions concerning the disease and treatment of the patient. However, sometimes the donor hesitates about the donation and has questions and concerns that might not be put forward if the patient or the physician responsible for the patient is present.
If the sibling is not sure that the confidentiality rules are followed there is a risk that the sibling does not dare to decline HLA-typing and donation. The sibling must be confident that if he/she declines donation, this information is confidential and no notes about the reason are recorded in the medical files of the patient or the donor. A very important goal of our structure is to avoid any HLA-typing of siblings who will later decline. If that happens the treatment process for the patient can be delayed, and there is an obvious risk that the family relations might be severely damaged.
We conclude that the search for a sibling donor should be performed in a way that as far as possible respects the sibling's integrity and confidentiality towards the patient and the rest of the family. When a suitable sibling donor is identified, it is important that proper information and support should be given not only before and during donation but also afterwards, as needed. Blood Centre Department, University Hospital, Lund, Sweden E-mail: annika.m.kisch@skane.se
HLA-typed siblings 120
Not HLA-typed siblings 11
Not HLA-identical siblings 89
HLA-identical siblings 31
Siblings who have donated: 17
Siblings who have not donated: 14 Figure 1 Siblings of potential allogeneic-SCT-patients.
